Publications in Non-Refereed Journals
  1. Singh G, Rabin B, Griffith B, Thompson M, Nalesnik M, Hardesty R: Post-transplant monitoring in cardiac allografts. Transplant Proc 15:1802-1803, 1983.
  2. Demetris AJ, Nalesnik MA, Bound LM, Kung HW, Shinozuka H, Gill TJ: Cyclosporine-associated atypical lymphoid hyperplasia in rats. Transplant Proc 17:1284-1296, 1985.
  3. Nalesnik MA, Todo S, Murase N, Gryzan S, Lee PH, Starzl TE: Toxicology of FK506 in the Lewis rat. Transplant Proc 19(50):89-92, 1987.
  4. Murase N, Todo S, Lee P, Lai HS, Chapman F, Nalesnik MA, Makowka L, Starzl TE: Heterotopic heart transplantation in the rat receiving FK506 alone or with Cyclosporine. Transplant Proc 19(5):71-75, 1987.
  5. Demetris AJ, Markus BH, Burnham J, Nalesnik M, Gordon RD, Makowka L, Starzl TE: Antibody deposition in liver allografts with chronic rejection. Transplant Proc 19(4):121-125, 1987.
  6. Todo S, Murase N, Kahn D, Pan CE, Okuda K, Cemej S, Casavilla A, Mazzaferro V, Ghalab A, Rhoe BS, Yang M, Taniguchi K, Nalesnik M, Makowka L and Starzl TE: Effect of 15-Deoxyspergaulin on experimental organ transplantation. Transplant Proc 20(1):233-236, 1988.
  7. Herlan D, Kormos R, Zeevi A, Paradis I, Wei L, Nalesnik M, Hardesty R and Griffith B: Dynamics of bronchoalveolar lavage in the canine lung transplant. Transplant Proc 20(1):832-835, 1988.
  8. Nalesnik MA, Locker J, Jaffe R, Demetris AJ, Hartle K, Burhnam JA, Makowka L and Starzl TE: Clonal characteristics of post-transplant lymphoproliferative disorders. Transplant Proc 20(1):280-283, 1988
  9. Paradis IL, Zeevi A, Duquesnoy RJ, Hardesty R, Kormos R, Nalesnik M, Dummer JS, Dauber JH, Griffith B: Immunologic aspects of chronic lung rejection in humans. Transplant Proc 20(1):812-814, 1988.
  10. Nalesnik MA, Lai HS, Murase N, Todo S, Starzl TE: The effect of FK605 and Cyclosporine A on the Lewis rat renal ischemia model. Transplant Proc 22(1):87-89, 1990.
  11. Murase N, Lieberman I, Nalesnik MA, Mintz D, Todo S, Drash AL, Starzl TE: FK506 prevents spontaneous diabetes in the BB rat. Transplant Proc 23(1):551-555, 1991.
  12. Nalesnik MA, Demetris AJ, Fung JJ, Starzl TE: Lymphoproliferative disorders arising under immunosuppression with FK506: Initial observations in a large transplant population. Transplant Proc 23(1):1108-1110, 1991.
  13. Stieber AO, Boillot O, Scotti-Foglieni C, Nalesnik MA, Gordon RD, Marino Im Mazzaferro V, Starzl TE: The surgical implications of the post-transplant lymphoproliferative disorders. Transplant Proc 23(1):1477-1479, 1991.
  14. Carrieri G, Murase N, Woo J, Nalesnik M, Azzarone A, Funakoshi Y, Thomson AW, Todo S, Starzl TE: Effect of FK506 in the prophylaxis of autoimmune glomerulonephritis in NZB/WF1 mice. Transplant Proc 23(6):3357-3359, 1991.
  15. Murase N, Demetris AJ, Woo J, Furuya T, Nalesnik M, Tanabe M, Todo S, Starzl TE: Lymphocyte traffic and graft-versus-host disease after fully allogeneic small bowel transplantation. Transplant Proc 23(6):3246-3247, 1991.
  16. Reyes J, Tzakis A, Green M, Nour B, Nalesnik M, Van Thiel D, Martin M, Breinig MK, Fung JJ, Cooper M: Post-transplant lymphoproliferative disorders occurring under primary FK506 immunosuppression. Transplant Proc 23(6):3044-3046, 1991.
  17. Thomson AW, Nalesnik M, Abu-Elmagd K, Starzl TE: Influence of FK506 on T lymphocytes, Langerhans’ cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: A preliminary study. Transplant Proc 23(6):3330-3331, 1991.
  18. Farghali H, Gasbarrini A, Borle AB, Nalesnik MA, Francavilla A, Fagiuolo S, Starzl TE, Van Thiel DH: FK506 modulates D-galactosamine-induced hepatitis in rats. Transplant Proc 23(6):2809-2811, 1991.
  19. Nakamura K, Nalesnik M, Todo S, Takenaka T, Yagihashi A, Iwaki Y, Abu-Elmagd K, Reyes J, Tzakis A, Warty V: Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 24(3):1197-1198, 1992.
  20. DiSilvio M, Murase N, Rilo HL, Nussler AK, Ildstad ST, Nalesnik MA, Ricordi C: Intrathymic transplantation of hepatocytes is facilitated by the addition of pancreatic islets. Transplant Proc 24(6):2987, 1992.
  21. Cooper MH, Hoffman RA, Jacob TD, Nalesnik MA, DiSilvio M, Ildstad ST: Xenogeneic graft-versus-host disease is associated with elevated levels of reactive nitrogen intermediates. Transplant Proc 24(6):2872-2873, 1992.
  22. Nakamura K, Nalesnik M, Jaffe R, Todo S, Tzakis A, Abu-Elmagd K, Reyes J, Wright H, Murase N, Van Thiel DH, Fung JJ, Starzl TE and Demetris AJ: Morphological monitoring of human small bowel allografts. Transplant Proc 25:1212,1993.
  23. Cooper MH, Nalesnik MA, Watkins SC, Schachter MJ, Ildstad ST: Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response. Transplant Proc 25:1283, 1993.
  24. Reyes J, Zeevi A, Ramos H, Tzakis A, Todo S, Demetris AJ, Nour B, Nalesnik M, Trucco M, Abu-Elmagd K, Fung JJ, Starzl TE: Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 25(6):3315-3319, 1993.
  25. Cicalese L, Caraceni Pk Nalesnik MA, Lee KKW, Van Thiel DH, Schraut WH: Oxygen free radicals formation is related to mucosal injury during reperfusion after rat small bowel transplantation. Transplant Proc 26:1477, 1994.
  26. Reyes J, Tzakis AG, Bonet H, Green M, Yunis E, Nalesnik M, Nour B, Kocoshis S, Abu-Elmagd K, Todo S, et al. Lymphoproliferative disease after intestinal transplantation under primary FK506 immunosuppression. Transplant Proc 26:1426-7, 1994.
  27. Mueller AR, Platz KP, Nalesnik MA, Langrehr JM, Neuhaus P, Schraut WH: Small bowel preservation causes basement membrane and endothelial cell injury. Transplant Proc 26:1498-1500, 1994.
  28. Wu TT, Swerdlow S, Locker J, Randhawa PS, Yunis E, Reyes J, Fung JJ, Starzl TE and Nalesnik MA: Pathologic analysis of recurrent post-transplant lymphoproliferative disorders. Transplantation Proc, 27(1):1193-1194, 1995.
Book Chapters
  1. Makowka L, Nalesnik MA, Stieber A, Jaffe R, Ho M, Iwatsuki S, Demetris AJ, Griffith BP, Breinig MK, Starzl TE: Control of post-transplant lymphoproliferative disorders and Kaposi’s sarcoma by modulation of immunosuppresion. In: Nature, Cellular and Biochemical Bases, and Management of Immunodeficiency. RA Good, ed., FK Schattauer Verlag, Stuttgart-New York, pp. 567-624, 1987.
  2. Nalesnik MA, Locker J: EBV-associated lymphoproliferative disorders in a large transplant population. In: Epstein-Barr Virus and Human Disease, II, Humana Press, 1988.
  3. Thomson AW, Murase N, Nalesnik MA and Starzl TE: The influence of tacrolimus (FK506) on experimental autoimmune disease. In: Principles of Drug Development for Transplantation and Autoimmunity, Raven, Press, 1994.
  4. Nalesnik MA, Demetris, AJ: Pathology of Liver Transplantation in: Liver Transplantation (Cillo et al- 1994).